Cite
TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer Treatment
MLA
Shuai Guo, et al. “TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer Treatment.” International Journal of Molecular Sciences, vol. 22, no. 20, Oct. 2021, p. 10930. EBSCOhost, https://doi.org/10.3390/ijms222010930.
APA
Shuai Guo, Xue Bai, Sai Shi, Yawen Deng, Xianjiang Kang, & Hailong An. (2021). TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer Treatment. International Journal of Molecular Sciences, 22(20), 10930. https://doi.org/10.3390/ijms222010930
Chicago
Shuai Guo, Xue Bai, Sai Shi, Yawen Deng, Xianjiang Kang, and Hailong An. 2021. “TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer Treatment.” International Journal of Molecular Sciences 22 (20): 10930. doi:10.3390/ijms222010930.